Page 9 - 2018_12-Haematologica-web
P. 9
Acute Myeloid Leukemia
2033 Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
Lionel Adès et al.
2040 Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey
Pierre Bories et al.
Non-Hodgkin Lymphoma
2049 Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma
Afua A. Mensah et al.
2059 Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma Shiori Kinoshita et al.
Chronic Lymphocytic Leukemia
2069 Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways Lynne V. Abruzzo et al.
Plasma Cell Disorders
2079 Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Andrew Spencer et al.
2088 Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
Meletios A. Dimopoulos et al.
Platelet Biology & its disorders
2097 Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
Phillip L.R. Nicolson et al.
Stem Cell Transplantation
2109 Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics Fatma Keklik et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/103/12.toc
e561 Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity
Simon Berhe et al. http://www.haematologica.org/content/103/12/e561
e564 Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene Frances Smith et al.
http://www.haematologica.org/content/103/12/e564
haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
Haematologica 2018; vol. 103 no. 12 - December 2018 http://www.haematologica.org/
